--- title: "Compounded mAbs - Cancer Therapies" ocid: "ocds-h6vhtk-0693de" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0693de" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0693de.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0693de.json" source: "Find A Tender Service" current_stage: "Tender" buyer: "BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST" published: "2026-05-12" --- # Compounded mAbs - Cancer Therapies Buyer: BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST Current stage: Tender OCID: ocds-h6vhtk-0693de [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0693de) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0693de.json) ## Summary The procurement process involves the Berkshire Healthcare NHS Foundation Trust as the buying organisation, seeking suppliers for a framework agreement titled "Compounded mAbs - Cancer Therapies". This initiative is set in the industry category of pharmaceutical products and services and is located across various NHS Trusts in the South East of England. The procurement is currently in the tender stage, with key deadlines including the enquiry period closing on 16th June 2026, and the tender submission deadline set for 22nd June 2026. The framework is structured into two lots: Lot 1 for high-volume products and Lot 2 for lower-volume products, each with an active contract period starting on 1st December 2026 and extending through to 30th November 2028, with options for renewal. This tender represents a significant opportunity for businesses involved in the pharmaceutical sector, particularly those specialising in monoclonal antibodies for chemotherapy treatments. Suitably positioned small and medium-sized enterprises (SMEs) and voluntary, community, and social enterprises (VCSEs) can leverage this open procurement procedure to secure a place in the framework. The opportunity facilitates business growth through a potential framework value of £216 million, providing a stable pipeline of demand over several years. Businesses capable of meeting technical compliance, quality assurance benchmarks, and competitive pricing criteria are well-suited to compete, with the procurement process allowing for new players to enter the market. ## Notice Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters' Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framework via MPSC. Please note: we did not publish a preliminary market engagement notice (UK2) for the following reasons: - we are not seeking to further develop our requirements or procurement approach. - we have procured similar supply arrangements via the Open procedure and deployed similar conditions of participation and award criteria. These have yielded good results previously. - we have already prepared our tender pack (see attached), that detail standard NHS contractual terms which have been found to be acceptable to the supply chain. - we understand the likely suppliers who will be interested but the open notice approach gives opportunity to others looking to enter the mAbs supply market ### Lot Information Lot 1 High Volume Products - 5 molecules / all brands Options: Option for 2 x 12 month extension (maximum duration 4 years). Renewal: Option for 2 x 12 month extension (maximum duration 4 years). Lot 2 Lower Volume Products - 13 molecules / all brands Options: Option for 2 x 12 month extension (maximum duration 4 years). Renewal: Option for 2 x 12 month extension (maximum duration 4 years). ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/043323-2026 | | Notice type | UK4 - Tender Notice | | Procurement type | Framework | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | SME, VCSE | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 12 May 2026 | | Submission deadline | 22 Jun 2026 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | 1 Dec 2026 - 30 Nov 2028 | | Recurrence | 2029-07-02 | ## Values | Field | Value | | --- | --- | | Tender value | £216,000,000 | | Lots value | £216,000,000 | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST | | Locality | BRACKNELL | | Post town | Reading | | Postcode | RG12 2UT | | Country | England | | ITL 1 | TLJ South East (England) | | ITL 2 | TLJ1 Berkshire, Buckinghamshire and Oxfordshire | | ITL 3 | TLJ15 Berkshire East | | Local authority | Bracknell Forest | | Electoral ward | Bullbrook | | Westminster constituency | Bracknell | | Delivery location | TLJ South East (England) | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products - 85 - Health and social work services ### Codes - 33600000 - Pharmaceutical products - 85149000 - Pharmacy services ## Release History - 12 May 2026 at 08:47 - TenderUpdate - UK4 - Tender Notice - https://www.find-tender.service.gov.uk/Notice/043323-2026 - 7 May 2026 at 15:42 - Tender - UK4 - Tender Notice - https://www.find-tender.service.gov.uk/Notice/042148-2026 ## Documents - https://www.find-tender.service.gov.uk/Notice/043323-2026 12th May 2026 - Tender notice on Find a Tender - https://www.find-tender.service.gov.uk/Notice/042148-2026 7th May 2026 - Tender notice on Find a Tender - https://www.find-tender.service.gov.uk/Notice/Attachment/A-15858 ## Notice URLs - https://health-family.force.com/s/Welcome - https://www.berkshirehealthcare.nhs.uk/ - https://www.legislation.gov.uk/ukpga/2023/54/contents ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0693de. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0693de.json.